Taking Science to Impact
HCM Info Session
The 14-week Diploma of Advanced Studies Health Care and Management (DAS HCM): From Research to Implementation course provides participants with the core competencies for understanding and reacting to health challenges at a world-leading institute in global health.
Learn more about the course at the next info evening on 12 April 2021 at 18:00 CET. Join the session online!
Building a Fairer, Healthier World
As a part of World Health Day 2021, we take a look back on our Impact Stories blog post written by Swiss TPH's Martina Ragettli & Martin Röösli, which outlines the importance of using the experience of COVID-19 to be better prepared in tackling future crisis, and make faster decisions in order to prevent them.
Read the blog post now
Interpreting Epidemiological Trends and Models
Join us to review the history of mathematical epidemiology and modelling, its world wide prominence over the last 12 months, and why we are discussing the science behind COVID-19 modelling and epidemiology data today.
Swiss TPH Symposium: Global Health in the 21st Century
Though much progress has been made in improving global health, many new obstacles have emerged. Join the Swiss TPH Virtual Symposium 2021 to discuss the challenges and opportunities ahead, what cutting-edge research has to offer, and case studies from around the world.
Register nowNews
Alle News
01.04.2021
Die Pollensaison beginnt wegen dem Klimawandel früher und wird intensiver
Schlechte Nachrichten für Allergikerinnen und Allergiker: Der Temperaturanstieg in den vergangenen drei Jahrzehnten hat dazu geführt, dass die Pollensaison in der Schweiz früher... More...
31.03.2021
Promising Treatment Alternative Against Parasitic Worm Infection
Strongyloidiasis, a parasitic worm infection caused by soil-transmitted helminths, remains a neglected public health problem with limited treatment options. Swiss TPH researchers... More...
24.03.2021
Clinical Trial of Multi Drug-Resistant TB Treatment Ends Enrolment Early, Offering Hope for TB Patients
A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board... More...